scholarly journals In vivo imaging of therapy response to a novel Pan-HER antibody mixture using FDG and FLT positron emission tomography

Oncotarget ◽  
2015 ◽  
Vol 6 (35) ◽  
pp. 37486-37499 ◽  
Author(s):  
Carsten H. Nielsen ◽  
Mette M. Jensen ◽  
Lotte K. Kristensen ◽  
Anna Dahlman ◽  
Camilla Fröhlich ◽  
...  
Keyword(s):  
Positron Emission Tomography ◽  
In Vivo Imaging ◽  
Therapy Response ◽  
Emission Tomography ◽  
Positron Emission ◽  
Antibody Mixture

scholarly journals Correction to: In vivo imaging of early stages of rheumatoid arthritis by α5β1-integrin-targeted positron emission tomography

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Johannes Notni ◽  
Florian T. Gassert ◽  
Katja Steiger ◽  
Peter Sommer ◽  
Wilko Weichert ◽  
...  
Keyword(s):  
Rheumatoid Arthritis ◽  
Positron Emission Tomography ◽  
In Vivo Imaging ◽  
Emission Tomography ◽  
Early Stages ◽  
Positron Emission ◽  
Α5β1 Integrin

Following publication of the original article [1], the authors have reported an error in the ‘Histopathology’ (under ‘Materials and methods’) section of the article that compromises the reproducibility of the paper.

scholarly journals In Vivo Imaging of Insulin Receptors in Monkeys Using 18F-Labeled Insulin and Positron Emission Tomography

Diabetes ◽  
1992 ◽  
Vol 41 (7) ◽  
pp. 855-860 ◽  
Author(s):  
R. C. Eastman ◽  
R. E. Carson ◽  
K. A. Jacobson ◽  
Y. Shai ◽  
M. A. Channing ◽  
...  
Keyword(s):  
Positron Emission Tomography ◽  
In Vivo Imaging ◽  
Insulin Receptors ◽  
Emission Tomography ◽  
Positron Emission

scholarly journals In vivo imaging of synaptic loss in Alzheimer’s disease with [18F]UCB-H positron emission tomography

2019 ◽  
Vol 47 (2) ◽  
pp. 390-402 ◽  
Author(s):  
Christine Bastin ◽  
Mohamed Ali Bahri ◽  
François Meyer ◽  
Marine Manard ◽  
Emma Delhaye ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Positron Emission Tomography ◽  
In Vivo Imaging ◽  
Emission Tomography ◽  
Synaptic Loss ◽  
Positron Emission

Design, Radiosynthesis, and Biodistribution of a New Potent and Selective Ligand for in Vivo Imaging of the Adenosine A2AReceptor System Using Positron Emission Tomography

2000 ◽  
Vol 43 (23) ◽  
pp. 4359-4362 ◽  
Author(s):  
Sergio Todde ◽  
Rosa Maria Moresco ◽  
Pasquale Simonelli ◽  
Pier Giovanni Baraldi ◽  
Barbara Cacciari ◽  
...  
Keyword(s):  
Positron Emission Tomography ◽  
In Vivo Imaging ◽  
Emission Tomography ◽  
Positron Emission ◽  
Selective Ligand

In vivo imaging of adenovirus-mediated over-expression of dopamine D2 receptors in rat striatum by positron emission tomography

Neuroreport ◽  
2000 ◽  
Vol 11 (4) ◽  
pp. 743-748 ◽  
Author(s):  
Osamu Ogawa ◽  
Hiroyuki Umegaki ◽  
Kiichi Ishiwata ◽  
Yukako Asai ◽  
Hiroyuki Ikari ◽  
...  
Keyword(s):  
Positron Emission Tomography ◽  
In Vivo Imaging ◽  
D2 Receptors ◽  
Dopamine D2 Receptors ◽  
Emission Tomography ◽  
Rat Striatum ◽  
Over Expression ◽  
Dopamine D2 ◽  
Positron Emission

scholarly journals Towards In Vivo Imaging of Cancer Sialylation

2011 ◽  
Vol 2011 ◽  
pp. 1-10 ◽  
Author(s):  
Ivan Martinez-Duncker ◽  
Roberta Salinas-Marin ◽  
Carlos Martinez-Duncker
Keyword(s):  
Positron Emission Tomography ◽  
Carbohydrate Metabolism ◽  
In Vivo Imaging ◽  
Emission Tomography ◽  
Invasion And Metastasis ◽  
Complementary Information ◽  
Positron Emission ◽  
Key Points ◽  
Worse Prognosis

In vivo assessment of tumor glucose catabolism by positron emission tomography (PET) has become a highly valued study in the medical management of cancer. Emerging technologies offer the potential to evaluate in vivo another aspect of cancer carbohydrate metabolism related to the increased anabolic use of monosaccharides like sialic acid (Sia). Sia is used for the synthesis of sialylated oligosaccharides in the cell surface that in cancer cells are overexpressed and positively associated to malignancy and worse prognosis because of their role in invasion and metastasis. This paper addresses the key points of the different strategies that have been developed to image Sia expression in vivo and the perspectives to translate it from the bench to the bedside where it would offer the clinician highly valued complementary information on cancer carbohydrate metabolism that is currently unavailable in vivo.

Sign in / Sign up

Export Citation Format

Share Document